Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness

Prostate cancer accounts for approximately 13.5% of all newly diagnosed male cancer cases. Significant clinical burdens remain in terms of ineffective prognostication, with overtreatment of insignificant disease. Additionally, the pathobiology underlying disease heterogeneity remains poorly understo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Main Authors: Flynn, Louise, Barr, Martin P., Baird, Anne-Marie, Smyth, Paul, Casey, Orla M., Blackshields, Gordon, Greene, John, Pennington, Stephen R., Hams, Emily, Fallon, Padraic G., O’Leary, John, Sheils, Orla, Finn, Stephen P.
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7347552/
https://ncbi.nlm.nih.gov/pubmed/32647229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-68187-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares